Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Changes in CYP1A2 activity in humans after 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) administration using caffeine as a probe drug.
Yubero-Lahoz S, Pardo R, Farre M, Mathuna BÓ, Torrens M, Mustata C, Perez-Mañá C, Langohr K, Carbó ML, de la Torre R. Yubero-Lahoz S, et al. Among authors: carbo ml. Drug Metab Pharmacokinet. 2012;27(6):605-13. doi: 10.2133/dmpk.dmpk-12-rg-032. Epub 2012 May 22. Drug Metab Pharmacokinet. 2012. PMID: 22673010 Free article.
Clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): the influence of gender and genetics (CYP2D6, COMT, 5-HTT).
Pardo-Lozano R, Farré M, Yubero-Lahoz S, O'Mathúna B, Torrens M, Mustata C, Pérez-Mañá C, Langohr K, Cuyàs E, Carbó Ml, de la Torre R. Pardo-Lozano R, et al. Among authors: carbo ml. PLoS One. 2012;7(10):e47599. doi: 10.1371/journal.pone.0047599. Epub 2012 Oct 24. PLoS One. 2012. PMID: 23112822 Free PMC article. Clinical Trial.
Dose-Response Pharmacological Study of Mephedrone and Its Metabolites: Pharmacokinetics, Serotoninergic Effects, and Impact of CYP2D6 Genetic Variation.
Olesti E, Farré M, Carbó ML, Papaseit E, Perez-Mañá C, Torrens M, Yubero-Lahoz S, Pujadas M, Pozo ÓJ, de la Torre R. Olesti E, et al. Among authors: carbo ml. Clin Pharmacol Ther. 2019 Sep;106(3):596-604. doi: 10.1002/cpt.1417. Epub 2019 Apr 8. Clin Pharmacol Ther. 2019. PMID: 30815856 Clinical Trial.
Metabolomics predicts the pharmacological profile of new psychoactive substances.
Olesti E, De Toma I, Ramaekers JG, Brunt TM, Carbó ML, Fernández-Avilés C, Robledo P, Farré M, Dierssen M, Pozo ÓJ, de la Torre R. Olesti E, et al. Among authors: carbo ml. J Psychopharmacol. 2019 Mar;33(3):347-354. doi: 10.1177/0269881118812103. Epub 2018 Nov 19. J Psychopharmacol. 2019. PMID: 30451567
Effect of quinolones on caffeine disposition.
Carbó M, Segura J, De la Torre R, Badenas JM, Camí J. Carbó M, et al. Clin Pharmacol Ther. 1989 Mar;45(3):234-40. doi: 10.1038/clpt.1989.23. Clin Pharmacol Ther. 1989. PMID: 2920498 Clinical Trial.
19 results